Jump to content

Laura J. van 't Veer

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Kennethaw88 (talk | contribs) at 04:29, 6 October 2015 (fixing date parameter). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Laura J. van 't Veer
NationalityDutch
Alma materUniversity of Amsterdam B.Sc in Biology and M.Sc in Molecular Oncology, University of Leiden Ph.D.
AwardsIARC Medal of Honor (2005), ESMO Lifetime Achievement Award for Translational Research in Breast Cancer (2007), Breast Cancer Research Fund (BCRF-Pink Ribbon US) grant award (2007) (2008), European Inventor Award (2015)
Scientific career
Fieldsclinical medicine
InstitutionsThe Netherlands Cancer Institute,Agendia BV, University of California, San Francisco
Thesis (1989)

Laura J. van 't Veer is a Molecular Biologist, Clinical Molecular Geneticist, and Group Leader Molecular Pathology for the Department of Pathology and Division of Experimental Therapy of The Netherlands Cancer Institute[1]

Education

Attended the University of Amsterdam from 1976–1984 and received a B.Sc in Biology and M.Sc in Molecular Oncology. She continued her studies at the University of Leiden from 1984–1989. She would earn her PhD focusing on the study of Oncogene Activation and Tumorigenesis.

Career

In 2003 Dr. van ‘t Veer cofounded Agendia B.V. in 2003, serving as the Chief Operating Officer of Agendia B.V. until June 12, 2007. She continues her work with the company today as Chief Research Officer.[2] She was featured in the cover story of the MAY-JUNE 2006 issue of Cancer World. [3] With her colleagues in the field, she has been awarded a number of patents related to cancer treatment.[4] Has been a member of the Science Policy and Government Affairs Committee of the American Association for Cancer Research since 2014. From 2013–2014 she was a member of the Education and Training Committee. [5] She has more than 80 peer reviewed publications to her name. [6]

Awards and Merits

  • IARC Medal of Honor, Lyon, France in 2005
  • Van der Scheuren award lecture for European Breast Cancer Research, EBCC5 in 2006.
  • ESMO Lifetime Achievement Award for Translational Research in Breast Cancer in 2007
  • Breast Cancer Research Fund (BCRF-Pink Ribbon US) grant award in 2007 and 2008
  • Delivered the First Annual Harry and Edith Gladstein Award, Indiana University, School of Medicine in April 7, 2009 titled "Molecular Profiles of Breast and Colorectal Cancer in Patient Management" [7]
  • European Inventor Award, in 2015 for her gene-based breast cancer test.

References

  1. ^ "Profile of Laura J. van 't Veer, PhD". University of San Francisco. University of San Francisco. Retrieved 2015-02-26.
  2. ^ "PROF. DR. LAURA VAN 'T VEER". http://www.agendia.com/. AGENDIA. Retrieved 3 March 2015. {{cite web}}: External link in |website= (help)
  3. ^ Beishon, Marc (May–June 2006). "Laura van 't Veer: the person behind personalised treatments" (PDF). Cancer World: 6–13. Retrieved 3 March 2015.
  4. ^ "Patents by Inventor Laura J. Van't Veer". justia.com. justia. Retrieved 3 March 2015.
  5. ^ "Standing Committees". http://www.aacr.org/. American Association of Cancer Research. Retrieved 3 March 2015. {{cite web}}: External link in |website= (help)
  6. ^ "Appendix BSpeaker Biographical Sketches". http://www.ncbi.nlm.nih.gov/. National Academy of Sciences. Retrieved 3 March 2015. {{cite web}}: External link in |website= (help)
  7. ^ Indiana University. Indiana University http://medicine.iupui.edu/clinpharm/seminar/gladstein/. Retrieved 26 February 2015. {{cite web}}: Missing or empty |title= (help)

Template:Persondata

Retrieved from "https://en.wikipedia.org/w/index.php?title=Laura_J._van_%27t_Veer&oldid=684360467"